K2M Posts 1Q17 Revenue, Announces Product Approvals in Japan

By Julie A. Vetalice

K2M posted 1Q17 revenue of US $61.9MM, +9.9% vs. 1Q16. (U.S. $46.2MM, +9.5%; ex-U.S. $15.7MM, +11.1%) Following 1Q, the company received key product registrations from Japan’s Pharmaceuticals and Medical Devices Agency, and can now implement a new distribution strategy in that region.

Member-Only Content


Product Labels: Spinal Fusion

Tags: Regulatory